Kilitch Drugs (India) Limited (BSE: 524500)
Health Care · Pharmaceuticals · IN
Rs162.00
-9.27% today · -16.4% 1Y
Kilitch Drugs (India) Limited (BSE: 524500) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $59.20M.
Over the last twelve months the share price has lost 16.4%, trading between 121.10 and 219.68.
Tweenvest scores Kilitch Drugs (India) Limited across four factors: quality 69/100, value 58/100, growth 90/100. Its strongest factor is growth.
524500 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $59.20M
- Revenue (TTM)
- $25.09M
- P/E
- 18.64
- EPS
- 8.69
- Dividend yield
- —
- Beta (5Y)
- 0.36
- 52-week high
- Rs219.68
- 52-week low
- Rs121.10
- Avg volume (3M)
- —
- Shares outstanding
- 34.96M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.